Acute interstitial nephritis with Prothionamide.

SAGE Open Med Case Rep

USAID Eliminate TB Project, KNCV Tuberculosis Foundation, Hawassa, Ethiopia.

Published: May 2022

Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction. In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy. This drug-related side effect had not been reported. In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide. The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect. It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109270PMC
http://dx.doi.org/10.1177/2050313X221094076DOI Listing

Publication Analysis

Top Keywords

acute interstitial
16
interstitial nephritis
16
case report
12
nephritis prothionamide
8
acute renal
8
renal failure
8
failure acute
8
acute
7
drug-related
6
report
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!